Expert Insights
ETF Channels
ETF Strategist
China Insights
Nasdaq Investment Intelligence
Fixed Income
Leveraged & Inverse
Multi-Factor
Retirement ETF
ESG
ETF Building Blocks
Core Strategies
Disruptive Technology
Innovative ETFs
Dividend
Model Portfolio
Multi-Asset
Thematic Investing
Entrepreneur ETF
Gold & Silver Investing
Smart Beta
Active ETF
Equity ETF
Beyond Basic Beta
ETF Education
Crypto
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
ETF Education
First Bitcoin ETF
Newsletter
New ETFs
ETF Ecosystem
Education Central
ETF Playbook
Videos & Podcasts
Videos
ETF Prime Podcast
ETF 360 Video Series
Podcasts
Events
Exchange: An ETF Experience
ETFs Future-Forward 2021: An iShares Investing Symposium
Three Themes for 2021: An iShares & MSCI Investing Symposium
Salix
Featured
Salix Bidding War Provides Modest Boost for Pharma ETFs
By
Todd Shriber
March 11, 2015
X
